Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D'Arena

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Leukemia|January 8, 2011
E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemiaI Saborit-Villarroya, T Vaisitti, D Rossi, et al.
Mini Reviews in Medicinal Chemistry|May 13, 2011
Natural compounds in anti-leukaemic therapy: a reviewL De Martino, G D'Arena, R Filosa, et al.
Haematologica|May 1, 1997
All-trans retinoic acid in combination with alpha-interferon and dexamethasone for advanced multiple myelomaP Musto, M R Sajeva, G Sanpaolo, et al.
Haematologica|May 9, 1998
Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic featuresG D'Arena, P Musto, N Cascavilla, et al.
Leukemia & Lymphoma|November 8, 2001
Morphologically typical and atypical B-cell chronic lymphocytic leukemias display a different pattern of surface antigenic densityG D'Arena, M Dell'Olio, P Musto, et al.
Journal of Hematotherapy & Stem Cell Research|January 14, 2000
Inability of activated cord blood T lymphocytes to perform Th1-like and Th2-like responses: implications for transplantationG D'Arena, P Musto, N Cascavilla, et al.
Leukemia & Lymphoma|November 9, 2001
CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemiaG D'Arena, P Musto, N Cascavilla, et al.
Mini Reviews in Medicinal Chemistry|May 13, 2011
CD38 in chronic lymphocytic leukemia: from bench to bedside?S Deaglio, T Vaisitti, S Serra, et al.
International Journal of Immunopathology and Pharmacology|January 16, 2010
Verbena officinalis essential oil and its component citral as apoptotic-inducing agent in chronic lymphocytic leukemiaL De Martino, G D'Arena, M M Minervini, et al.
Bone Marrow Transplantation|April 15, 2003
Should we continue to study high-dose chemotherapy in metastatic breast cancer patients? A critical review of the published dataA Tartarone, G Romano, R Galasso, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Leukemia|January 8, 2011
E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemiaI Saborit-Villarroya, T Vaisitti, D Rossi, et al.
Mini Reviews in Medicinal Chemistry|May 13, 2011
Natural compounds in anti-leukaemic therapy: a reviewL De Martino, G D'Arena, R Filosa, et al.
Haematologica|May 1, 1997
All-trans retinoic acid in combination with alpha-interferon and dexamethasone for advanced multiple myelomaP Musto, M R Sajeva, G Sanpaolo, et al.
Haematologica|May 9, 1998
Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic featuresG D'Arena, P Musto, N Cascavilla, et al.
Leukemia & Lymphoma|November 8, 2001
Morphologically typical and atypical B-cell chronic lymphocytic leukemias display a different pattern of surface antigenic densityG D'Arena, M Dell'Olio, P Musto, et al.
Journal of Hematotherapy & Stem Cell Research|January 14, 2000
Inability of activated cord blood T lymphocytes to perform Th1-like and Th2-like responses: implications for transplantationG D'Arena, P Musto, N Cascavilla, et al.
Leukemia & Lymphoma|November 9, 2001
CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemiaG D'Arena, P Musto, N Cascavilla, et al.
Mini Reviews in Medicinal Chemistry|May 13, 2011
CD38 in chronic lymphocytic leukemia: from bench to bedside?S Deaglio, T Vaisitti, S Serra, et al.
International Journal of Immunopathology and Pharmacology|January 16, 2010
Verbena officinalis essential oil and its component citral as apoptotic-inducing agent in chronic lymphocytic leukemiaL De Martino, G D'Arena, M M Minervini, et al.
Bone Marrow Transplantation|April 15, 2003
Should we continue to study high-dose chemotherapy in metastatic breast cancer patients? A critical review of the published dataA Tartarone, G Romano, R Galasso, et al.
Pageof 5